हिंदी में पढ़ें

Fortis Healthcare

Fortis Healthcare Q1 PAT rises 40 percent to Rs 174 crore

Fortis Healthcare Q1 PAT rises 40 percent to Rs 174 crore

Wed, Aug 07, 2024

Fortis Healthcare reports a 40% increase in consolidated profit after tax to Rs 174 crore for Q1 FY24, driven by strong hospital business performance. Revenue rose to Rs 1,859 crore. The company plans to add nearly 700 beds this fiscal year and is exploring growth opportunities despite a lower performance in its diagnostics business.

Fortis lines up Rs 1,300 crore capex to expand existing hospitals

Fortis lines up Rs 1,300 crore capex to expand existing hospitals

Tue, May 28, 2024

He noted that the healthcare provider is looking to add bed capacity at various existing facilities, including hospitals in Faridabad and Anandpur Sahib."At Faridabad, there is space available, and we have planned to further expand..In regard to Anandpur, we have acquired a company with a different land parcel.

This multi-bagger hospital stock hits new high; it is expected to rise another 17%

This multi-bagger hospital stock hits new high; it is expected to rise another 17%

Mon, Jan 01, 2024

Stock market today, stock market news, buzzing stocks: On the last trading day of CY23, the stock ended over 3 per cent higher at Rs 419.2 per share on the NSE.

TRENDING NOW

Fortis Healthcare extends deadline for submission of binding bids to June 28

Fortis Healthcare extends deadline for submission of binding bids to June 28

Tue, Jun 12, 2018

Last month, Fortis Healthcare had initiated a fresh time-bound bidding process for its sale after terminating the offer made by the Munjal-Burman combine. The earlier deadline for submitting fresh binding bids was June 14.

Fortis Healthcare appoints Ravi Rajagopal as chairman

Fortis Healthcare appoints Ravi Rajagopal as chairman

Fri, Jun 01, 2018

Ravi Rajagopal in his 35 years long career has worked in various entities like ITC, Ranbaxy Laboratories and Diageo.

Fortis Healthcare launches new bidding process

Fortis Healthcare launches new bidding process

Tue, May 29, 2018

Fortis`s board earlier this month approved an investment offer for 18 billion rupees ($265 million) from the Hero Enterprise Investment Office and the Burman Family Office consortium, but shareholders were lukewarm to the plan which waived due diligence. The planned stake size was not disclosed. Bidders in the new round should submit their offers by June 14, with a minimum investment of 15 billion rupees by way of preferential allotment. They were given 10 days to conduct financial and legal due diligence.

Fortis Healthcare undecided on reopening bidding process

Fortis Healthcare undecided on reopening bidding process

Tue, May 29, 2018

The Hero Enterprise Investment Office and Burman Family Office’s offer this month to invest 18 billion rupees ($267 million) in the company did not go down well with Fortis shareholders, who voted out a director last week. Three directors resigned ahead of the vote.

Fortis Healthcare gets approval from Hero-Burman to re-open bidding

Fortis Healthcare gets approval from Hero-Burman to re-open bidding

Mon, May 28, 2018

Fortis Healthcare said it has received a letter from Hero Enterprise Investment Office and Burman family Officer ...Giving their consent to re-open the bidding process to enable the company to move ahead with the fund-raising transaction.

Fortis Healthcare sale: Manipal-TPG extends validity of its 'modified new offer'

Fortis Healthcare sale: Manipal-TPG extends validity of its 'modified new offer'

Fri, May 25, 2018

Fortis Healthcare (FHL) has said that a consortium of Manipal-TPG has extended the validity of its "modified" new offer to invest in the company. As per a late night BSE filing on Wednesday, FHL said that its Board has received a letter from Manipal-TPG for extending the validity of their "modified" new offer till June 6 from the earlier date of May 29.

Fortis Healthcare investors vote out fourth director after divisive investment decision

Fortis Healthcare investors vote out fourth director after divisive investment decision

Wed, May 23, 2018

Fortis has received five offers from local and international suitors wanting to invest in the firm or buy it. Though in need of funds, the company has become an attractive asset as private healthcare spending grows in India while the government expands access to insurance in a country lacking adequate health facilities.

Insider trading at Fortis Healthcare? Watchdog eyeing a scam

Insider trading at Fortis Healthcare? Watchdog eyeing a scam

Wed, May 23, 2018

Market regulator Securities and Exchange Board of India (Sebi) is probing suspected insider trading by some institutional investors and other regulatory lapses at Fortis Healthcare amid a takeover battle and boardroom upheaval at the hospital chain, officials said.

Independent director quits Fortis board ahead of stakeholders meet

Independent director quits Fortis board ahead of stakeholders meet

Sun, May 20, 2018

Fortis Healthcare today said its independent director, Lt Gen Tejinder Singh Shergill, has resigned from the board due to personal reasons

Fortis Healthcare share price rallies 4 pct after Manipal, TPG swoop in with sweetened bid

Fortis Healthcare share price rallies 4 pct after Manipal, TPG swoop in with sweetened bid

Tue, May 15, 2018

Fortis Healthcare share price rallied over 4 per cent after Manipal Hospital and private equity firm TPG Capital Management on Monday sweetened their bid to buy Fortis Healthcare, just days after the Fortis board said it favoured a rival offer to the dismay of many shareholders.

Fortis Healthcare sale: Manipal refuses to back-off from fight, makes fresh offer

Fortis Healthcare sale: Manipal refuses to back-off from fight, makes fresh offer

Tue, May 15, 2018

Barely days after, the Fortis Healthcare Board took a decision to go ahead with Hero Enterprise Investment Office-Burman Family Office offer, the consortium of Manipal Health Enterprises (MHE)-TPG Capital is yet to give up.

Fortis Healthcare share price slips 4%; should you buy?

Fortis Healthcare share price slips 4%; should you buy?

Fri, May 11, 2018

Fortis Healthcare share price slipped nearly 4 per cent on Friday after its board approved binding offer from Hero-Burman family offices.

Hero-Burman consortium set to buy Fortis Healthcare as board gives thumbs-up

Hero-Burman consortium set to buy Fortis Healthcare as board gives thumbs-up

Fri, May 11, 2018

The Munjal-Burmans combine had given their revised offer on May 1, which included an upfront equity infusion of Rs 800 crore at a price of Rs 167 per share into the company through preferential allotment, it added.

Fortis Healthcare overhaul demand: Directors warn of turbulence

Fortis Healthcare overhaul demand: Directors warn of turbulence

Thu, May 10, 2018

Minority shareholders - National Westminster Bank Plc as Trustee of Jupiter India Fund, East Bridge Capital Master Fund Ltd and East Bridge Capital Master Fund I Ltd had sought the removal of directors after the initial offer inked with Manipal Health Enterprises (MHE)-TPG Capital, which they said undervalued Fortis. The shareholders were also against excluding the non-binding offers and have demanded an extraordinary general meeting (EGM), which will now be held on May 22.

Latest bid for Fortis Healthcare more risky, says Manipal CEO

Latest bid for Fortis Healthcare more risky, says Manipal CEO

Tue, May 08, 2018

Fortis Healthcare has been a target of five firms and investment groups vying for control of its 30-odd hospitals across India. Among them is Malaysia’s IHH Healthcare, which wants to invest as much as 40 billion rupees at 175 rupees a share, higher than the share price offered by Manipal.

Fortis Healthcare bidding: Munjals-Burmans claim their proposal offer best value

Fortis Healthcare bidding: Munjals-Burmans claim their proposal offer best value

Mon, May 07, 2018

Hero Enterprises and Burman family today claimed their proposition for Fortis was the best offer for the healthcare major as it would value the company to up to Rs 9,000 crore.

Fortis Healthcare bidding war: A timeline

Fortis Healthcare bidding war: A timeline

Mon, May 07, 2018

Fortis Healthcare Ltd (FHL), which runs about 30 hospitals in India, has become a target of a heated takeover battle, with five entities bidding for the embattled company. Fortis has set up an advisory committee to evaluate binding offers from suitors vying to acquire the company, or take a stake

Battle for Fortis Healthcare: Manipal Health Enterprises-TPG Capital make final offer

Battle for Fortis Healthcare: Manipal Health Enterprises-TPG Capital make final offer

Mon, May 07, 2018

On May 1, Malaysian IHH Healthcare Berhad and Hero Enterprise Investment Office-Burman Family Office had sweetened their offers for Fortis by proposing an investment of Rs 4,375 crore at a price of Rs 175 per share. While Munjal-Burman has offered Rs 1,800 crore (without any due diligence) for three Board seats, up from their earlier Rs 1,500 crore for two seats.

Manipal Health further sweetens offer for Fortis Healthcare

Manipal Health further sweetens offer for Fortis Healthcare

Sun, May 06, 2018

The move is aimed at helping FHL deal with short term liquidity concerns, repayment of existing loans and payment for the acquisition of the relevant Indian entities from Religare Health Trust (RHT), MHEPL said in its revised offer to FHL board. Manipal Health Enterprises Pvt Ltd (MHEPL) has offered to merge it with FHL to create one of the leading healthcare platforms in India, the filing said

Fortis Healthcare sale: Manipal-TPG may emerge as biggest bidders even as rivals hike offers

Fortis Healthcare sale: Manipal-TPG may emerge as biggest bidders even as rivals hike offers

Wed, May 02, 2018

The bidding war for Fortis Healthcare doesn’t seem to end. Hero Enterprise Investment Office-Burman Family Office and Malaysian IHH Healthcare Berhad hiked their offers for the Gurugram-based hospital chain on Tuesday.

Load More

LIVE TV

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x